FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33592511000001102: Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Nov 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
101302801000001115 Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
101302901000001114 Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Epoprostenol 1.5mg powder and solvent (pH12) for solution for infusion vials true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has active ingredient Epoprostenol true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient Epoprostenol sodium true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has dispensed dose form Powder and solvent for solution for infusion true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Epoprostenol true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Flolan true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has manufactured dose form Powder and solvent for solution for infusion true Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has basis of strength substance Epoprostenol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial Has AMP True Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start